Hello, Guest
Login
Sign Up
 
 

Healthcare Stocks Alert: Mylan Inc, Zogenix, Affymax, Gilead Sciences

 
 
Repost This

Lakeway, TX -- (SBWIRE) -- 03/01/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Mylan Inc.(NASDAQ:MYL) added 4.25% and is trading at $29.78. Mylan, Inc. develops and markets generics along with a number of proprietary drugs. The Company's product is for the treatment of migraine headaches, an orphan drug for the on/off fluctuation in people with Parkinson's disease, and a wound care product to treat diabetic foot ulcers.

How Should Investors Trade MYL After The Recent Movement? Find Out Here

Zogenix, Inc.(NASDAQ:ZGNX) is higher 11.17% and is trading at $1.89. Zogenix, Inc. (Zogenix) is a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain. The Company’s product Sumavel DosePro offers needle-free subcutaneous administration of sumatriptan for the treatment of migraine and cluster headache in a pre-filled, single-use delivery system.

Is ZGNX Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

Affymax, Inc.(NASDAQ:AFFY) is lower 1.87% and is trading at $2.62 Affymax, Inc. is a biopharmaceutical company engaged in developing drugs to improve the treatment of serious and often life-threatening conditions.

Is AFFY a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

Gilead Sciences, Inc.(NASDAQ:GILD) is higher 0.29% and is trading at $43.01. Gilead Sciences, Inc. (Gilead) is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Gilead’s primary areas of focus include human immunodeficiency virus (HIV)/AIDS, liver diseases, such as hepatitis B and C and cardiovascular/metabolic and respiratory conditions.

How Should Investors Trade GILD After The Latest Earnings Report? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.